{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:47:27Z","timestamp":1790642847631,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-021-08078-3","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:03:15Z","timestamp":1623949395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients without known coronary artery disease"],"prefix":"10.1007","author":[{"given":"Th\u00e9o","family":"Pezel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Garot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Kinnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Unterseeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hovasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenn","family":"Toupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Garot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"8078_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A et al (2019) Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation 139:e56\u2013e528. https:\/\/doi.org\/10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"8078_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamacardio.2019.0035","volume":"4","author":"JF Heitner","year":"2019","unstructured":"Heitner JF, Kim RJ, Kim HW et al (2019) Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48\u00a0000 patient-years of follow-up. JAMA Cardiol 4:256\u2013264. https:\/\/doi.org\/10.1001\/jamacardio.2019.0035","journal-title":"JAMA Cardiol"},{"key":"8078_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jacc.2019.07.074","volume":"74","author":"RY Kwong","year":"2019","unstructured":"Kwong RY, Ge Y, Steel K et al (2019) Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. J Am Coll Cardiol 74:1741\u20131755. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.074","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jcmg.2020.02.029","volume":"13","author":"Y Ge","year":"2020","unstructured":"Ge Y, Pandya A, Steel K et al (2020) Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes. JACC Cardiovasc Imaging 13:1505\u20131517. https:\/\/doi.org\/10.1016\/j.jcmg.2020.02.029","journal-title":"JACC Cardiovasc Imaging"},{"key":"8078_CR5","doi-asserted-by":"publisher","unstructured":"Antiochos P, Ge Y, Steel K et al (2020) Evaluation of stress cardiac magnetic resonance imaging in risk reclassification of patients with suspected coronary artery disease. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.2834","DOI":"10.1001\/jamacardio.2020.2834"},{"key":"8078_CR6","doi-asserted-by":"publisher","unstructured":"Stacey RB, Vera T, Morgan TM et al (2018) Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals. J Cardiovasc Magn Reson 20. https:\/\/doi.org\/10.1186\/s12968-018-0492-5","DOI":"10.1186\/s12968-018-0492-5"},{"key":"8078_CR7","doi-asserted-by":"publisher","unstructured":"Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF (2005) Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 26:1402\u20131409. https:\/\/doi.org\/10.1093\/eurheartj\/ehi169","DOI":"10.1093\/eurheartj\/ehi169"},{"key":"8078_CR8","doi-asserted-by":"publisher","unstructured":"Knuuti J, Wijns W, Saraste A et al (2019) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"8078_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.jacc.2012.03.003","volume":"59","author":"MR Patel","year":"2012","unstructured":"Patel MR, Bailey SR, Bonow RO et al (2012) ACCF\/SCAI\/AATS\/AHA\/ASE\/ASNC\/HFSA\/HRS\/SCCM\/SCCT\/SCMR\/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 59:1995\u20132027. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.003","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jacc.2013.11.009","volume":"63","author":"MJ Wolk","year":"2014","unstructured":"Wolk MJ, Bailey SR, Doherty JU et al (2014) ACCF\/AHA\/ASE\/ASNC\/HFSA\/HRS\/SCAI\/SCCT\/SCMR\/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 63:380\u2013406. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.009","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR11","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Authors\/Task Force Members, Ryd\u00e9n L, Grant PJ et al (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035\u20133087. https:\/\/doi.org\/10.1093\/eurheartj\/eht108","journal-title":"Eur Heart J"},{"key":"8078_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00019501-200109000-00009","volume":"12","author":"M Bonou","year":"2001","unstructured":"Bonou M, Benroubis A, Kranidis A et al (2001) Functional and prognostic significance of silent ischemia during dobutamine stress echocardiography in the elderly. Coron Artery Dis 12:499\u2013506. https:\/\/doi.org\/10.1097\/00019501-200109000-00009","journal-title":"Coron Artery Dis"},{"key":"8078_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/hrt.2004.041087","volume":"91","author":"E Biagini","year":"2005","unstructured":"Biagini E, Schinkel AFL, Bax JJ et al (2005) Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart 91:737\u2013742. https:\/\/doi.org\/10.1136\/hrt.2004.041087","journal-title":"Heart"},{"key":"8078_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/01.cir.101.3.244","volume":"101","author":"ZX He","year":"2000","unstructured":"He ZX, Hedrick TD, Pratt CM et al (2000) Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 101:244\u2013251. https:\/\/doi.org\/10.1161\/01.cir.101.3.244","journal-title":"Circulation"},{"key":"8078_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijcard.2017.05.069","volume":"244","author":"MJ Zellweger","year":"2017","unstructured":"Zellweger MJ, Haaf P, Maraun M et al (2017) Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus. Int J Cardiol 244:37\u201342. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.069","journal-title":"Int J Cardiol"},{"key":"8078_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-020-01019-2","volume":"19","author":"M-Y Ng","year":"2020","unstructured":"Ng M-Y, Zhou W, Vardhanabhuti V et al (2020) Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study. Cardiovasc Diabetol 19:42. https:\/\/doi.org\/10.1186\/s12933-020-01019-2","journal-title":"Cardiovasc Diabetol"},{"key":"8078_CR17","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1093\/eurheartj\/ehy267","volume":"39","author":"J Knuuti","year":"2018","unstructured":"Knuuti J, Ballo H, Juarez-Orozco LE et al (2018) The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J 39:3322\u20133330. https:\/\/doi.org\/10.1093\/eurheartj\/ehy267","journal-title":"Eur Heart J"},{"key":"8078_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jcmg.2017.02.006","volume":"10","author":"G Vincenti","year":"2017","unstructured":"Vincenti G, Masci PG, Monney P et al (2017) Stress perfusion CMR in patients with known and suspected CAD. JACC Cardiovasc Imaging 10:526\u2013537. https:\/\/doi.org\/10.1016\/j.jcmg.2017.02.006","journal-title":"JACC Cardiovasc Imaging"},{"key":"8078_CR19","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jcmg.2011.04.015","volume":"4","author":"OR Coelho-Filho","year":"2011","unstructured":"Coelho-Filho OR, Seabra LF, Mongeon F-P et al (2011) Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient\u2019s sex. JACC Cardiovasc Imaging 4:850\u2013861. https:\/\/doi.org\/10.1016\/j.jcmg.2011.04.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"8078_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"8078_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72:2231\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"KA Hicks","year":"2015","unstructured":"Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials. J Am Coll Cardiol 66:403\u2013469. https:\/\/doi.org\/10.1016\/j.jacc.2014.12.018","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR23","doi-asserted-by":"publisher","unstructured":"Pezel T, Sanguineti F, Kinnel M et al (2020) Prognostic value of dipyridamole stress perfusion cardiovascular magnetic resonance in elderly patients >75 years with suspected coronary artery disease. Eur Heart J Cardiovasc Imaging. https:\/\/doi.org\/10.1093\/ehjci\/jeaa193","DOI":"10.1093\/ehjci\/jeaa193"},{"key":"8078_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jcmg.2019.12.002","volume":"13","author":"M Kinnel","year":"2020","unstructured":"Kinnel M, Garot J, Pezel T et al (2020) Prognostic value of vasodilator stress perfusion CMR in morbidly obese patients (BMI \u226540\u00a0kg\/m2) without known CAD. JACC Cardiovasc Imaging 13:1276\u20131277. https:\/\/doi.org\/10.1016\/j.jcmg.2019.12.002","journal-title":"JACC Cardiovasc Imaging"},{"key":"8078_CR25","doi-asserted-by":"publisher","unstructured":"Pezel T, Sanguineti F, Kinnel M et al (2020) Safety and prognostic value of vasodilator stress cardiovascular magnetic resonance in patients with heart failure and reduced ejection fraction. Circ Cardiovasc Imaging 13. https:\/\/doi.org\/10.1161\/CIRCIMAGING.120.01059926","DOI":"10.1161\/CIRCIMAGING.120.01059926"},{"key":"8078_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539\u2013542","journal-title":"Circulation"},{"key":"8078_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/eurheartj\/ehm617","volume":"29","author":"J Schwitter","year":"2008","unstructured":"Schwitter J, Wacker CM, van Rossum AC et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480\u2013489. https:\/\/doi.org\/10.1093\/eurheartj\/ehm617","journal-title":"Eur Heart J"},{"key":"8078_CR28","doi-asserted-by":"publisher","unstructured":"Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461\u20131474. https:\/\/doi.org\/10.1093\/eurheartj\/ehi258","DOI":"10.1093\/eurheartj\/ehi258"},{"key":"8078_CR29","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","volume":"343","author":"RJ Kim","year":"2000","unstructured":"Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445\u20131453. https:\/\/doi.org\/10.1056\/NEJM200011163432003","journal-title":"N Engl J Med"},{"key":"8078_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0195-668x(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987\u20131003. https:\/\/doi.org\/10.1016\/s0195-668x(03)00114-3","journal-title":"Eur Heart J"},{"key":"8078_CR31","doi-asserted-by":"crossref","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837\u20131847","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"8078_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2020.06.063","volume":"76","author":"P Antiochos","year":"2020","unstructured":"Antiochos P, Ge Y, Steel K et al (2020) Imaging of clinically unrecognized myocardial fibrosis in patients with suspected coronary artery disease. J Am Coll Cardiol 76:945\u2013957. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.063","journal-title":"J Am Coll Cardiol"},{"key":"8078_CR33","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00330-018-5774-7","volume":"29","author":"S G\u00f3mez-Revelles","year":"2019","unstructured":"G\u00f3mez-Revelles S, Rossello X, D\u00edaz-Villanueva J et al (2019) Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR. Eur Radiol 29:2263\u20132271. https:\/\/doi.org\/10.1007\/s00330-018-5774-7","journal-title":"Eur Radiol"},{"key":"8078_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/CIRCULATIONAHA.112.000071","volume":"129","author":"JP Greenwood","year":"2014","unstructured":"Greenwood JP, Motwani M, Maredia N et al (2014) Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation 129:1129\u20131138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000071","journal-title":"Circulation"},{"key":"8078_CR35","doi-asserted-by":"publisher","first-page":"79.e1","DOI":"10.1016\/j.crad.2020.07.038","volume":"76","author":"Z Yang","year":"2021","unstructured":"Yang Z, Fu H, Li H et al (2021) Late gadolinium enhancement is a risk factor for major adverse cardiac events in unrecognised myocardial infarction without apparent symptoms: a meta-analysis. Clin Radiol 76:79.e1\u201379.e11. https:\/\/doi.org\/10.1016\/j.crad.2020.07.038","journal-title":"Clin Radiol"},{"key":"8078_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.cir.0000047041.66447.29","volume":"107","author":"RJ Gibbons","year":"2003","unstructured":"Gibbons RJ, Abrams J, Chatterjee K et al (2003) ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107:149\u2013158. https:\/\/doi.org\/10.1161\/01.cir.0000047041.66447.29","journal-title":"Circulation"},{"key":"8078_CR37","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff","year":"2014","unstructured":"Goff DC, Lloyd-Jones DM, Bennett G et al (2014) 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129:S49\u2013S73. https:\/\/doi.org\/10.1161\/01.cir.0000437741.48606.98","journal-title":"Circulation"},{"key":"8078_CR38","doi-asserted-by":"publisher","unstructured":"Monmeneu Menadas JV, Lopez-Lereu MP, Estornell Erill J, Gonzalez PG, Mu\u00f1oz BI, Gonzalez AM (2016) Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry. Eur Heart J Cardiovasc Imaging 17:308\u2013315. https:\/\/doi.org\/10.1093\/ehjci\/jev153","DOI":"10.1093\/ehjci\/jev153"},{"key":"8078_CR39","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395\u20131407. https:\/\/doi.org\/10.1056\/NEJMoa1915922","journal-title":"N Engl J Med"},{"key":"8078_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.amjcard.2015.01.556","volume":"115","author":"H Gada","year":"2015","unstructured":"Gada H, Kirtane AJ, Kereiakes DJ et al (2015) Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. Am J Cardiol 115:1194\u20131199. https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.556","journal-title":"Am J Cardiol"},{"key":"8078_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jcin.2018.10.049","volume":"12","author":"A Czarnecki","year":"2019","unstructured":"Czarnecki A, Qiu F, Elbaz-Greener G et al (2019) Variation in revascularization practice and outcomes in asymptomatic stable ischemic heart disease. JACC Cardiovasc Interv 12:232\u2013241. https:\/\/doi.org\/10.1016\/j.jcin.2018.10.049","journal-title":"JACC Cardiovasc Interv"},{"key":"8078_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2018.08.006","volume":"277","author":"KH Choi","year":"2019","unstructured":"Choi KH, Lee JM, Park I et al (2019) Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia. Int J Cardiol 277:47\u201353. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.006","journal-title":"Int J Cardiol"},{"key":"8078_CR43","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","volume":"380","author":"E Nagel","year":"2019","unstructured":"Nagel E, Greenwood JP, McCann GP et al (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. N Engl J Med 380:2418\u20132428. https:\/\/doi.org\/10.1056\/NEJMoa1716734","journal-title":"N Engl J Med"},{"key":"8078_CR44","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jcmg.2020.04.001","volume":"13","author":"E Nagel","year":"2020","unstructured":"Nagel E, Chandrashekhar Y (2020) Stress-Only CMR. JACC Cardiovasc Imaging 13:1296\u20131298. https:\/\/doi.org\/10.1016\/j.jcmg.2020.04.001","journal-title":"JACC Cardiovasc Imaging"},{"key":"8078_CR45","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00330-015-4064-x","volume":"26","author":"G Pontone","year":"2016","unstructured":"Pontone G, Andreini D, Bertella E et al (2016) Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. Eur Radiol 26:2155\u20132165. https:\/\/doi.org\/10.1007\/s00330-015-4064-x","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08078-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T06:02:43Z","timestamp":1623996163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08078-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":45,"alternative-id":["8078"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08078-3","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Pr Jerome Garot.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Solenn Toupin is an employee of Siemens Healthcare. Other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}